Phenotype Standardization for Statin-Induced Myotoxicity

被引:176
作者
Alfirevic, A. [1 ]
Neely, D. [2 ]
Armitage, J. [3 ]
Chinoy, H. [4 ]
Cooper, R. G. [5 ]
Laaksonen, R. [6 ]
Carr, D. F. [1 ]
Bloch, K. M. [1 ]
Fahy, J. [1 ]
Hanson, A. [1 ]
Yue, Q-Y [7 ]
Wadelius, M. [8 ]
Maitland-van der Zee, A. H. [9 ]
Voora, D. [10 ]
Psaty, B. M. [11 ,12 ,13 ]
Palmer, C. N. A. [14 ]
Pirmohamed, M. [1 ]
机构
[1] Univ Liverpool, Inst Translat Med, TheWolfson Ctr Personalised Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Clin Biochem, Newcastle Upon Tyne, Tyne & Wear, England
[3] Clin Trial Serv Unit, Oxford, England
[4] Univ Manchester, NIHR Manchester Musculoskeletal Biomed Res Unit, Ctr Musculoskeletal Res, Manchester, Lancs, England
[5] Univ Liverpool, Fac Hlth & Life Sci, MRC ARUK Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England
[6] Zora Biosci Ltd, Espoo, Finland
[7] Med Prod Agcy, Uppsala, Sweden
[8] Uppsala Univ, Clin Pharmacol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden
[9] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[10] Duke Inst Genome Sci & Policy, Durham, NC USA
[11] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA
[12] Univ Washington, Dept Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA USA
[13] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA
[14] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland
关键词
INDUCED MYOPATHY; HOSPITALIZED RHABDOMYOLYSIS; PLASMA-CONCENTRATIONS; GENETIC VARIANT; GEMFIBROZIL; SIMVASTATIN; THERAPY; SLCO1B1; TRIALS; SAFETY;
D O I
10.1038/clpt.2014.121
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis. Research in this area has been hampered to some extent by the lack of standardized nomenclature and phenotypic definitions. We have used numerical and descriptive classifications and developed an algorithm to define statin-related myotoxicity phenotypes, including myalgia, myopathy, rhabdomyolysis, and necrotizing autoimmune myopathy.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 70 条
[1]
Methods for causality assessment of adverse drug reactions - A systematic review [J].
Agbabiaka, Taofikat B. ;
Savovic, Jelena ;
Ernst, Edzard .
DRUG SAFETY, 2008, 31 (01) :21-37
[2]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[3]
Preempting and preventing drug-induced liver injury [J].
Aithal, Guruprasad P. ;
Daly, Ann K. .
NATURE GENETICS, 2010, 42 (08) :650-651
[4]
[Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.CIR.0000437738.63853.7A
[5]
Clinical perspectives of statin-induced rhabdomyolysis [J].
Antons, KA ;
Williams, CD ;
Baker, SK ;
Phillips, PS .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05) :400-409
[6]
Plasma concentrations of active simvastatin acid are increased by gemfibrozil [J].
Backman, JT ;
Kyrklund, C ;
Kivistö, KT ;
Wang, JS ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (02) :122-129
[7]
Statin safety: An overview and assessment of the data-2005 [J].
Bays, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A) :6C-26C
[8]
The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes [J].
Behr, Elijah R. ;
January, Craig ;
Schulze-Bahr, Eric ;
Grace, Andrew A. ;
Kaeaeb, Stefan ;
Fiszman, Monica ;
Gathers, Shaniece ;
Buckman, ShaAvhree ;
Youssef, Ashraf ;
Pirmohamed, Munir ;
Roden, Dan .
EUROPEAN HEART JOURNAL, 2013, 34 (26) :1958-1963
[9]
Etiology and frequency of rhabdomyolysis [J].
Black, C ;
Jick, H .
PHARMACOTHERAPY, 2002, 22 (12) :1524-1526
[10]
Managing statin-induced muscle toxicity in a lipid clinic [J].
Blaier, O. ;
Lishner, M. ;
Elis, A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) :336-341